Targeting renal cell carcinoma

J Clin Oncol. 2009 Jul 10;27(20):3274-6. doi: 10.1200/JCO.2009.21.8461. Epub 2009 May 18.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Renal Cell / blood
  • Carcinoma, Renal Cell / drug therapy*
  • Clinical Trials, Phase III as Topic
  • Disease-Free Survival
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Neoplasms / blood
  • Kidney Neoplasms / drug therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Prognosis
  • Pyridines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Sorafenib
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Vascular Endothelial Growth Factor A
  • Niacinamide
  • Sorafenib